| Literature DB >> 21052531 |
John F Howlett1, Victoria A Betteridge, Martine Champ, Stuart A S Craig, Agnes Meheust, Julie Miller Jones.
Abstract
A definition for dietary fiber was adopted in June 2009 by the Codex Alimentarius Commission based on the recommendation for endorsement of the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) in November 2008. The definition listed three categories of carbohydrate polymers that are not hydrolyzed by the endogenous enzymes in the small intestine of humans. However, the definition left the inclusion of carbohydrates with degrees of polymerization (DP) in the range of 3 and 9 to the discretion of national authorities and left the 'physiological effect(s) of benefit to health' as undefined. The ILSI Europe and ILSI North America's committees on dietary carbohydrates organized a forum at the Ninth Vahouny Fiber Symposium in 2010 to discuss these implementation issues with the objective of building scientific consensus on how to resolve them. The results of this session are encouraging and indicated that the scientific community agrees on maintaining a worldwide consensus regarding the inclusion of non-digestible carbohydrates with ≥DP3 as dietary fiber and on a core, non-exhaustive list of beneficial physiological effects that dietary fibers have. These results are consistent with previous worldwide agreements.Entities:
Keywords: Codex Alimentarius; Vahouny Symposium; degree of polymerization; dietary fiber; physiological effects
Year: 2010 PMID: 21052531 PMCID: PMC2972185 DOI: 10.3402/fnr.v54i0.5750
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.894
Fig. 1Survey circulated during the ILSI North America – ILSI Europe session.
Seventy-five responses to the survey questionnaire were received and summarized
| Positive answer | Negative answer | No answer | |
|---|---|---|---|
| Agree with the inclusion of DP 3–9 | 86.7% | 2.7% | 10.6%[ |
| Agree with physiological response: | |||
| • Reduction in blood total and/or LDL cholesterol | 98.7% | 1.3% | – |
| • Reduction in postprandial blood glucose and/or insulin levels | 96% | 2.7% | 1.3% |
| • Increased stool bulk and/or decreased transit time | 98.7% | 1.3% | – |
| • Fermentability by colonic microflora | 82.7% | 6.7% | 10.6% |
| Proposed other physiological effects | 30.7% | 69.3% | |
Three persons declined to answer the question DP 3–9 on grounds of insufficient information to allow a decision and five persons left the answer to the question concerning DP 3–9 blank.